本文へ移動
cccskills
無料GitHub で公開

enda-monitor-pregnant-pai-patients

Suggests that pregnant patients with primary adrenal insufficiency be monitored for clinical signs of glucocorticoid over- or under-replacement such as normal weight or gain, fatigue, postural hypotension or hypertension, and hyperglycemia, with at least one review each trimester. Use when managing a pregnant patient with PAI to assess glucocorticoid dosing adequacy.

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md3.1 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Monitor Pregnant PAI Patients for Glucocorticoid Over- and Under-Replacement

STEP 1 — Gather Information

Collect maternal weight trends, self-reported fatigue, orthostatic blood pressure measurements (sitting and standing), fasting or random glucose, and review of current glucocorticoid dose and regimen.
Compile the data to assess for signs of glucocorticoid over- or under-replacement.

STEP 2 — Rule In / Rule Out

Determine if any of the following are present: abnormal weight trend (excessive gain or loss), new/worsening fatigue, postural hypotension (SBP drop >20 mmHg) or hypertension (SBP >140 mmHg), hyperglycemia (random glucose >140 mg/dL).
If any sign is present → proceed to Step 3; if none are present → continue routine prenatal care and reassess at the next trimester visit.

STEP 3 — Classify or Stratify

Classify the pattern: glucocorticoid over‑replacement suggested by weight gain, insomnia, peripheral edema, or hyperglycemia; glucocorticoid under‑replacement suggested by fatigue, weight loss, postural hypotension, hyperpigmentation, or nausea/vomiting.
Assign to over‑replacement, under‑replacement, or indeterminate category.

STEP 4 — Decide

If over‑replacement is suspected, consider reducing the glucocorticoid dose by 10‑20 %; if under‑replacement is suspected, consider increasing the dose by 10‑20 %; if indeterminate, maintain the current dose and schedule close clinical review in 2‑4 weeks.
Document the dose adjustment plan and arrange follow‑up assessment.

Clinical Guardrails / Mimics / Pitfalls

Symptoms such as fatigue, edema, and hyperglycemia can occur in normal pregnancy; avoid attributing all changes to glucocorticoid dosing without evaluating obstetric causes. Do not rely solely on serum cortisol or ACTH levels due to pregnancy‑induced increases in cortisol‑binding globulin. Ensure hyperglycemia is evaluated for gestational diabetes per standard prenatal care. Avoid abrupt dose changes; titrate gradually and monitor for adrenal crisis or Cushingoid signs.

Concrete Clinical Example

A 32‑year‑old woman with known PAI at 20 weeks gestation reports increased fatigue and occasional dizziness on standing; weight is stable; random glucose is 92 mg/dL. Orthostatic BP shows a systolic drop of 25 mmHg without edema. Clinical suspicion of glucocorticoid under‑replacement leads to an increase in hydrocortisone from 20 mg to 25 mg daily in divided doses, with reassessment in 2 weeks.

Source: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-1710

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する